Histologic Evaluation of Lung Cancer Invasion: More Difficult Than Meets the Eye

IASLC Announces Results of 2023 Board of Directors Election

JTO Continues to Rank Among the Most-Cited Oncology Journals

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

In Case You Missed It: IASLC Launches New Education Center

IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion

In Case You Missed It: Recent News from IASLC

IASLC Names New Chief Science Officer

IASLC Calls For Documentation of Tobacco Use in Cancer Clinical Trials

IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers

In Brief for January 10, 2024

IASLC Launches Multiple Initiatives as Work on its New Strategic Plan Begins